In human solid and liquid tumor biopsies, “omic” technologies, are exploited to generate and integrate transcriptional and mutational profiles in search for new biomarkers with prognostic relevance.
Main research projects:
- Characterization of the mechanism of platinum resistance in Epithelial ovarian cancer.
- Analysis of serum miRNA expression and circulating tumor DNA (ctDNA) mutational profile.
- Mode of action of Trabectedin in mixoid liposarcomas.